Featured Multi
Testing Blog - limited to 3 posts
Dr. Fabrice Jean-Pierre: Uncovering the Invisible Battles in CF Lungs
Dr. Fabrice Jean-Pierre’s research digs into a problem many people with cystic fibrosis (CF) know intimately: chronic lung infections. Even as treatments like Trikafta improve lung function and overall quality of life for many, bacteria like Pseudomonas aeruginosa (PA) continue to linger, evolve, and resist treatment. Over time, PA can cause significant inflammation and tissue damage in the lungs, contributing to a decline in lung health.
Dr. Brad Quon: Investigating Inflammation in the Trikafta Era
Dr. Brad Quon, a Clinician-Scientist at the University of British Columbia, is asking bold, urgent questions amid the game-changing impact of CFTR modulators like Trikafta: Is inflammation still a problem? Who still needs treatment beyond Trikafta? How can we personalize care to meet every patient’s need?
Alyftrek: Your Questions Answered
Alyftrek: Your Questions Answered You might be wondering: What is Alyftrek? If so, you’re in the right place. We’ve answered some of the most common questions about Alyftrek to help you understand the latest on the newest cystic fibrosis (CF) treatment option.
Featured Multi
Testing News - limited to 3 posts
Health Canada approves CF drug Alyftrek for Canadians with Cystic Fibrosis
On July 22, 2025, Health Canada approved the new cystic fibrosis drug Alyftrek for people in Canada with cystic fibrosis aged six and older with the most common CF mutation, F508del, and for those with at least one responsive mutation in the CFTR gene.
Cystic Fibrosis Canada 2024-25 Impact Report | 65 Years of Progress
Discover Cystic Fibrosis Canada’s 2024-25 Impact Report. See how 65 years of research, advocacy, and community support are reshaping the future for Canadians living with cystic fibrosis.
Cystic Fibrosis Canada opens 2025 research grant competition
Canadian researchers in CF, including links to diabetes/cancer, can apply for 2026 funding. New: Seed Trial Planning Grants & a Publication Prize.
Featured Multi Carousel
Testing News - pagination for all posts
1 / 4
Featured Full Width Carousel
Testing - should be used for Blog or Events only (uses image).
Dr. Fabrice Jean-Pierre: Uncovering the Invisible Battles in CF Lungs
Dr. Fabrice Jean-Pierre’s research digs into a problem many people with cystic fibrosis (CF) know intimately: chronic lung infections. Even as treatments like Trikafta improve lung function and overall quality of life for many, bacteria like Pseudomonas aeruginosa (PA) continue to linger, evolve, and resist treatment. Over time, PA can cause significant inflammation and tissue damage in the lungs, contributing to a decline in lung health.
Featured Post + Vertical List
Testing - should be used for Blog or Events only (uses image).
Shine Season is back — and it’s your chance to make an impact.
This summer, join CARSTAR locations across Canada in raising critical funds for cystic fibrosis through Shine Season, the company’s annual fundraising campaign running from June to September.
Jun 1, 2025
Points East Lighthouse Run
The Points East Lighthouse Run/Relay is taking place on Saturday, June 14, 2025! Sign up a team of four members or run the 29-kilometer course as a solo event.
Jun 14, 2025
Gear Up 4 CF
The 20th Annual GearUp4CF is an annual cycling event established in 2008 in B.C., that unites cyclists in a fundraising initiative for Cystic Fibrosis Canada. Pedal with us as we harness the power of community and collective effort to generate financial support for the CF community.
Jun 21, 2025